Jun 04, 2020
Duchesnay USA and FabOverFifty launch Straight Talk: Sex and the Menopausal Woman video
Jan 07, 2020
Coming Soon: A Menopausal Solution That's Not All About Sex
Nov 06, 2019
Endoceutics® Receives Health Canada Approval for INTRAROSA®
Oct 18, 2019
Survey Reveals that Menopausal Women Prefer Oral Medication Over Topical Options to Treat Vaginal Dryness
Aug 20, 2019
Duchesnay USA launches three videos featuring gynecologist and menopause care specialist, Dr. Barb DePree
Jul 08, 2019
National Survey Launched to Identify Key Health Concerns Facing Menopausal Women
Jun 20, 2019
VuVatech Partners With The Octex Group to Manufacture Vaginal Dilators
Apr 11, 2019
Women's Excellence Gives Away One Free Session of Non-Surgical Laser Vaginal Rejuvenation at Upcoming Grand Opening Event
Jan 29, 2019
Duchesnay Inc. Receives Approval of Supplemental New Drug Application (sNDA) to Add Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause, to the Indication of Osphena® (ospemifene)
Oct 29, 2018
Duchesnay USA, Maker of Osphena®, Applauds Expanded Coverage for Treatments for Dyspareunia due to Menopause under Medicare Part D
Oct 25, 2018
Research Published in 'Menopause' During Breast Cancer Awareness Month Finds O-Shot® Procedure Could Help Breast Cancer Survivors Improve Sex
Aug 09, 2018
New Study on Vulvovaginal Atrophy (VVA) Concludes that VVA Needs More Attention and Intervention by Providers
Jul 24, 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Jul 19, 2018
Theramex to Exclusively License Intrarosa® In Europe, Australia, Russia and The Ukraine from Endoceutics
Jun 23, 2018
Dr. John R. Burroughs of Springs Aesthetics Now Offering vFit PLUS Feminine Wellness Treatment Device
Jun 15, 2018
Women's Excellence Treats Women With Vaginal Dryness and Painful Intercourse Without Surgery
Jun 12, 2018
Toro Management LLC DBA SYLK Proudly Announces the Launch of S.(H.E.) - an Educational Blog Series on Intimacy, Health and Wellness
May 30, 2018
A Little RF May Go Long Way in Relieving Vaginal Issues
May 30, 2018
TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY(TM) (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, due to Menopause
May 10, 2018
Dyspareunia: CMS Clarification Results In Expanded Treatment And Coverage Under Medicare Part D